恩替卡韦对改善乙型肝炎病毒相关性肾炎肾功能的临床观察
2018-01-31高志芳陈坚华潘燕芳刘金莲
高志芳+陈坚华+潘燕芳+刘金莲

【摘要】 目的 分析针对乙型肝炎病毒相关性肾炎患者以恩替卡韦用药治疗对其肾功能造成的影响。方法 60例乙型肝炎病毒相关性肾炎患者, 参考随机双盲分组法分为参考组和研究组, 每组30例。参考组行常规综合治疗;研究组在参考组治疗基础上加恩替卡韦联合治疗。治疗完毕后评估及比较两组治疗效果。结果 研究组治疗后总有效率为96.67%, 参考组治疗后总有效率为73.33%, 研究组治疗后总有效率明显高于参考组, 差异具有统计学意义(P<0.05)。结论 乙型肝炎病毒相关性肾炎患者以恩替卡韦用药治疗疗效显著, 可有效促进患者肝功、肾功的改善, 值得借鉴。
【关键词】 乙型肝炎病毒相关性肾炎;恩替卡韦;肾功能;疗效
DOI:10.14163/j.cnki.11-5547/r.2018.03.047
【Abstract】 Objective To analyze the effect of entecavir on renal function of patients with hepatitis B virus associated glomerulonephritis. Methods A total of 60 patients with hepatitis B virus associated glomerulonephritis were divided by random double-blind grouping method into control group and research group, with 30 cases in each group. The control group received routine comprehensive treatment, and the research group received entecavir on the basis of the control group. The treatment effect after treatment was evaluated and compared. Results After treatment, the research group had total effective rate as 96.67%, while the control group had total effective rate as 73.33%. The research group had obviously higher total effective rate after treatment than the control group, and the difference was statistically significant (P<0.05). Conclusion Entecavir shows remarkable efficacy for patients with hepatitis B virus associated glomerulonephritis, and can effectively promote the improvement of liver function and renal function. It is worthy of reference.
【Key words】 Hepatitis B virus associated glomerulonephritis; Entecavir; Renal function; Efficacy
慢性乙型肝炎为临床常见的慢性病, 肾脏是患者常受累的肝外脏器[1]。乙型肝炎病毒相关性肾炎患者的病情常迁延, 预后往往较差[2], 现今尚无明确的治疗方案。由于该疾病累及肝肾, 用药禁忌较多, 同时伴有免疫介导、病毒感染问题, 治疗难度较大, 行抗病毒药物治疗疗效欠佳。如何选择科学有效有效的治疗方案及时治疗该疾病已成为广大医师重点关注的问题。本文取本科室接收的60例乙型肝炎病毒相关性肾炎患者, 在常规综合治疗基础上加用恩替卡韦联合治疗, 可见效果满意, 现对治疗方案及效果总结如下。
1 资料与方法
1. 1 一般资料 收集本科室2015年5月~2017年5月接收的60例乙型肝炎病毒相关性肾炎患者, 纳入标准:①均满足乙型肝炎病毒相关性肾炎的相关诊断标准:血清乙肝病毒抗原检测呈阳性;明确诊断为肾小球肾炎且能排除继发性肾病;切片检测发现乙肝病毒抗原;②均无本研究相关药物过敏史;③均自愿参与本研究并签字;④经本院医学伦理研究委员会批准通过。……
